Myocardial Injury clinical trials

Explore recruiting myocardial injury clinical trials.

Recruiting myocardial injury studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Myocardial Injury trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Ivabradine for PREVENTion of Myocardial Injury after Noncardiac Surgery (MINS) - PREVENT-MINS Trial

Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

Post-Operative Atrial Fibrillation after Surgical Aortic Valve Replacement and the influence of HMG-CoA reductase inhibitors

Denmark

Therapeutic use (Phase IV) EU CTIS Study details

Randomised placebo controlled clinical trial of efficacy of MYOcardial protection in postacute inFLAMmatory cardiac involvEment due to COVID-19 (MYOFLAME-19)

Austria, Germany

Therapeutic confirmatory (Phase III) EU CTIS Study details

The effect of noradrenaline infusion versus standard blood pressure management on perioperative HYPotension in NOncaRdiac surgery.

Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

Multicenter, randomized, double-blind, Phase III study of intravenous TAD® 600 mg/4 ml solution for injection to evaluate efficacy and safety in preventing myocardial injury in patients with pneumonia

Italy

Therapeutic confirmatory (Phase III) EU CTIS Study details

Gene Therapy for Danon Disease: A Phase 2 Study Evaluating the Efficacy and Safety of Intravenously Administered Adeno-Associated Virus Serotype 9 (rAAV9) Vector Containing the Human LAMP2 Isoform B Transgene (RP-A501; AAV9.LAMP2B) in Male Patients with Danon Disease

Germany, Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Myocardial Injury trials by city

Myocardial Injury in Toronto Myocardial Injury in Vancouver Myocardial Injury in Montreal Myocardial Injury in Calgary Myocardial Injury in Edmonton Myocardial Injury in Ottawa Myocardial Injury in Winnipeg Myocardial Injury in Quebec City Myocardial Injury in Hamilton Myocardial Injury in Kitchener Myocardial Injury in London Myocardial Injury in Halifax Myocardial Injury in New York Myocardial Injury in Los Angeles Myocardial Injury in Chicago Myocardial Injury in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease